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Background: Diagnosing canine immune-mediated haemolytic anaemia (IMHA) is often challenging because all
currently available tests have their limitations. Dogs with IMHA often have an increased erythrocyte osmotic fragility
(OF), a characteristic that is sometimes used in the diagnosis of IMHA. Since the classic osmotic fragility test (COFT)
is time-consuming and requires specialized equipment, an easy and less labour-intensive rapid osmotic fragility test
(ROFT) has been used in some countries, but its diagnostic value has not yet been investigated.
This study aimed to evaluate erythrocyte osmotic fragility in dogs with and without IMHA, to compare results of
the classic (COFT) and rapid (ROFT) test and to assess the value of the ROFT as diagnostic test for canine IMHA.
Nineteen dogs with IMHA (group 1a), 21 anaemic dogs without IMHA (group 1b), 8 dogs with microcytosis (group 2),
13 hyperlipemic dogs (group 3), 10 dogs with lymphoma (group 4), 8 dogs with an infection (group 5) and 13 healthy
dogs (group 6) were included.
In all dogs, blood smear examination, in-saline auto-agglutination test, Coombs’ test, COFT and ROFT were performed.
In the COFT, OF5, OF50 and OF90 were defined as the NaCl concentrations at which respectively 5, 50 and 90% of
erythrocytes were haemolysed.
Results: Compared with healthy dogs, OF5 and OF50 were significantly higher in group 1a (P < 0.001) and OF5 was
significantly higher in group 3 (P = 0.0266). The ROFT was positive in 17 dogs with IMHA, 10 hyperlipemic dogs, one
anaemic dog without IMHA and one healthy dog.
Conclusions: Osmotic fragility was increased in the majority of dogs with IMHA and in dogs with hyperlipidemia, but
not in dogs with microcytosis, lymphoma or an infection. Although more detailed information was obtained about the
osmotic fragility by using the COFT, the COFT and ROFT gave similar results. The ROFT does not require specialized
equipment, is rapid and easy to perform and can be used easily in daily practice. Although, the ROFT cannot replace
other diagnostic tests, it may be a valuable additional tool to diagnose canine IMHA.
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The diagnosis of canine immune-mediated haemolytic
anaemia (IMHA) can be challenging as there is currently
no ‘gold standard’ [1,2]. Therefore, a diagnosis of IMHA
in dogs is clinically made based upon the presence of
haemolytic anaemia in combination with evidence of
immune-mediated destruction (marked spherocytosis
and/or a positive Coombs’ test or in-saline auto-
agglutination test) [1,3,4]. Spherocytosis is a strong indica-
tor of IMHA, but identification of spherocytes on blood
smears is subjective and can be difficult for practitioners
that do not evaluate blood smears on a daily basis [5].
Some authors suggest that when placed in a hypotonic
solution, spherocytes haemolyse at higher NaCl concen-
trations than normal red blood cells (RBCs), because of
their lower volume to surface ratio [5,6]. This may result
in an increased osmotic fragility (OF) [4]. Two protocols
to evaluate the OF have been described in dogs [5,6]. In
the first, which we named the classical OF test or the
COFT, 15 different NaCl concentrations are used to deter-
mine at which concentrations haemolysis is initiated and
subsequently completed [6]. In the second, which we
named the rapid OF test or the ROFT, OF is estimated
semi-quantitatively using only two NaCl concentrations
[5]. Since the COFT is time-consuming and requires spe-
cialized equipment, it is not applicable for use in daily
practice. Therefore, the easy and less labour-intensive
ROFT, could be an appealing alternative. The ROFT has
been used often in the diagnostic work up of canine
IMHA in Belgium and the Netherlands, but its diagnostic
value has never been evaluated [4,6]. Furthermore, the
literature about the influence of other systemic diseases or
pathologic conditions on OF is limited.
Increased RBC OF has already been reported as a fea-
ture of certain hereditary erythrocyte membrane defects
[7-15], microcytosis due to intestinal parasitism [16,17],
intoxications with β-acetylphenylhydrazin [18] and
hyperlipidemia [19]. An increase in OF, resulting in an-
aemia, has been observed in rabbits, rats, mice, guinea
pigs and dogs with experimentally induced hypercholes-
terolemia [19,20]. Although it has yet to be described in
dogs, hypertriglyceridemia can have similar effects on
RBCs [21,22]. Finally, severe liver insufficiency can induce
spur cell development with increased OF [19]. There are
no published studies evaluating OF in dogs with natural
occurring hyperlipidemia, neoplasia or infections.
The present study aimed to evaluate OF in anaemic
dogs with and without IMHA and in dogs with certain
specific clinical conditions for which an increased os-
motic fragility has already been described in human
studies or in experimental studies. Furthermore, results of
the COFT and ROFT were compared to evaluate if the
ROFT could be used as an alternative test for the labour-
intensive COFT. Finally, by calculating the sensitivity andspecificity of the ROFT in anaemic dogs we aimed to as-
sess the value of the ROFT as additional test to diagnose
canine IMHA.
Methods
A prospective clinical study was conducted between
January 2007 and August 2009.
Animals
All patients (mostly referral cases) were recruited at the
Faculty of Veterinary Medicine, Small Animal Clinic of
Ghent University.
Dogs with a moderate to severe anaemia (group 1)
were included if they had a packed cell volume (PCV)
prior to infusion therapy ≤ 30%, (reference interval: 43–
59%) and were divided into group 1a (dogs with IMHA)
and group 1b (dogs with anaemia due to conditions
other than IMHA). Diagnosis of IMHA was based on
the presence of haemolytic anaemia (hyperbilirubinemia,
haemoglobinaemia, bilirubinuria, haemoglobinuria) in
combination with either a moderate to marked spherocy-
tosis or a positive Coombs’ or in-saline auto-agglutination
test. Dogs with intravascular haemolysis, characterized by
the presence of haemoglobinaemia and/or haemoglobin-
uria that may or may not be combined with hyperbilirubi-
nemia and bilirubinuria as well as dogs with extravascular
haemolysis, characterized by hyperbilirubinemia and/or
bilirubinuria in absence of haemoglobinaemia and haemo-
globinuria, were included. In every dog diagnosed with
IMHA, further diagnostic examinations such as urinalysis,
thoracic radiographs, abdominal ultrasonography and, de-
pending on the patient history (travel history, geography,
seasonality), serology and/or PCR for blood parasites and
leptospirosis was performed to exclude an underlying dis-
ease such as neoplasia, an infection or the presence of a
metallic foreign body. Dogs were considered having pri-
mary IMHA if medical imaging studies did not reveal any
significant abnormalities and serology and/or PCR tests
for blood parasites or other infections were negative.
Group 1a and 1b dogs were considered having a regenera-
tive anaemia if they had an absolute reticulocyte count
over 60 000/μl. Dogs with microcytosis (group 2), anaemic
and non-anaemic, were included if they had a RBC mean
corpuscular volume (MCV) of ≤ 60 fl (reference interval:
63–77 fl). Breeds predisposed to microcytosis, such as
Shiba Inu and Akita Inu, were excluded [23]. Dogs with
hyperlipidemia (group 3) were included if they had a
fasted (minimum 12 hours) serum cholesterol (Chol) con-
centration of ≥ 12 mmol/l (reference interval: 3.33-
10.21 mmol/l) and/or triglyceride (TG) concentration ≥
2 mmol/l (reference interval: 0.02 – 1.86 mmol/l). Dogs
with multicentric lymphoma (group 4) were included
based on compatible clinical signs and cytology or histo-
pathology confirmed diagnosis. Dogs that were diagnosed
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ial) (group 5) joined the study if they showed compatible
clinical signs in combination with positive bacteriology,
serology and/or PCR results. Group 1–5 dogs that re-
ceived medication for longer than 3 days prior to admis-
sion and those for whom a definitive diagnosis could not
be made, were excluded. For group 1–5 there were no age
restrictions. Furthermore, except for group 2, all dog
breeds were considered for inclusion. The results of the
patient groups were compared to those of healthy, client-
owned dogs (group 6), older than 6 months, that had no
significant abnormalities on physical examination, com-
plete blood count (CBC) and serum biochemistry, and
did not receive any medication for two months prior to
enrolment. For the healthy dogs, we specifically selected
dogs that did not belong to breeds, in which hereditary
erythrocyte membrane defects associated with increased
OF have been described (Alaskan Malamute, Miniature
and Middle Schnauzers, Golden Retriever, Dutch Partridge
Dog, English Springer Spaniel, American Cocker Spaniel,
Whippet, Shetland Sheepdog, German Spaniel and
Beagle) [7-15].
All owners were informed about the purposes of the
study and signed a written consent to allow inclusion of
their dog.
Laboratory tests
Blood was collected by jugular vein puncture, stored at
4°C and analysed within 24 hours following collection.
Serum Chol and TG concentrations were measured in
every dog from group 2–6 on a fasted (minimum
12 hours) blood sample. Serum Chol and TG concentra-
tions were only measured in group 1 dogs if the dog had
been anorectic for at least 12 hours and if the clinical
condition of the dog allowed to take a sufficient amount
of blood to perform these measurements. Three blood
smears, stained with Diff-Quik (Diff-Quik Fix, Medion
Diagnostics, Düdingen, Switzerland), May-Grünwald
Giemsa (MGG) (Carl Roth, Karlsruhe, Germany) and New
Methylene Blue (Sigma-Aldrich, Steinheim, Germany)
were made. The degree of spherocytosis was mainly
assessed based on the MGG stained blood smears by
counting the number of spherocytes in 10 different oil
immersion fields (100×) (HPF), followed by calculating the
mean value per HPF. Dogs with <1 spherocyte, 1–3 spher-
ocytes, 3–5 spherocytes and ≥ 5 spherocytes per HPF were
defined as having ‘no’, ‘mild’, ‘moderate’ and ‘marked’
spherocytosis, respectively. The degree of spherocytosis
was initially determined when the patient was admitted
to the clinic by the primary clinician for that specific
case. Based on the findings in combination with the
other diagnostic tests a diagnosis was reached and treat-
ment was started. Afterwards, the blood smears of all
dogs were send off to the Department of Small AnimalClinical Sciences, Faculty of Health and Medical Sci-
ences, University of Copenhagen, Denmark to be evalu-
ated by Dr. A.T. Kristensen that was blinded from all
patient information (signalment, group, physical and
clinicopathologic abnormalities). Dogs were only included
in the study if there was no discordance in the number of
spherocytes found by the primary clinician and found by
Dr. Kristensen that would have resulted in a different
diagnosis for that patient.
The in-saline auto-agglutination test was carried out
by mixing one drop of EDTA blood with 4 drops of
NaCl 0.9% at room temperature on a smear slide. RBC
agglutination was immediately evaluated macroscopically
and microscopically [24-26]. A direct Coombs’ test was
performed on EDTA blood using the ID-Gel test anti-
canine globulin (DiaMed-VET, Morat, Switzerland), with
6 microtubes containing anti-canine globulin (rabbit
anti-IgG, anti-IgM and anti-C3) within the gel matrix
[27,28]. To perform the test, first a 0.8% red cell suspen-
sion was made by gently mixing 10 μl of packed cells
with 1.0 mL of ID-diluent VET 2. Of this red cell
suspension, 50 μL was added to each microtube of the
ID-Gel Test card. After which, the ID-Gel Test card was
centrifuged for 10 minutes in the ID-centrifuge. The test
was positive when agglutinated cells formed a red line
on the surface of the gel or agglutinates dispersed in the
gel. The test was negative when the cells lay on the bot-
tom of the microtubes. To avoid interference caused by
severe auto-agglutination, the RBCs of the patient were
first washed two times in phosphate buffered saline
(PBS; pH 7.4). Furthermore, a negative control was in-
cluded for every Coombs’ test, using negative control
cards that contain gel matrix without antibody.
The COFT and ROFT were performed on whole blood
with sodium heparin as anticoagulant, the former as de-
scribed by Jain (1986). Of a 10% PBS solution (pH 7.4)
15 5-mL dilutions, representing NaCl concentrations
from 0.85% to 0.10%, were made. A 16th tube contained
5 ml of distilled water. To each tube, 0.02 ml blood was
added and mixed by inversion. After standing 30 minutes
at room temperature, the tubes were centrifuged for
10 minutes at 795× g. The optical density of each super-
natant was established spectrophotometrically at 540 nm,
using distilled water as a blank. For each dilution the per-
centage of haemolysis was calculated by assuming the
haemolysis in the 16th tube to be a 100%. OF5, OF50 and
OF90 were determined as being the NaCl concentration
in which respectively 5, 50 and 90 per cent of the RBCs
were haemolysed. A derivative and a cumulative fragili-
gram were thus obtained [6].
For the ROFT, OF was estimated semi-quantitatively
using two NaCl solutions, 0.9% and 0.55% [5]. The first
tube contained 5 ml of NaCl 0.9% and the second 3 ml
of NaCl 0.9% diluted with 2 ml of distilled water. Five
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cubated for 5 minutes at room temperature and centri-
fuged for 5 minutes at 2431× g. The test was considered
positive when the supernatant was colourless or yellow
(due to hyperbilirubinemia) in the first tube and red in
the second tube, and characterized as negative when an
obvious colour difference between both tubes was not
discernible.
Statistical analysis
OF5, OF50 or OF90 were normally distributed according
to the Shapiro Wilk test; these variables were therefore
compared globally between different groups by the F-test.
All clinical groups were compared with the control
group using Dunnett’s adjustment technique to adjust
the P-value for multiple comparisons. The global signifi-
cance level was set at 0.05.
Different variables (PCV, MCV, number of sphero-
cytes, Chol, TG) were not normally distributed and were
compared between the ROFT positive and ROFT nega-
tive dogs and between the Coombs positive and Coombs
negative dogs using Wilcoxon rank sum test with a glo-
bal significance level at 0.05. Furthermore, by using the
same test, OF50 was compared between the Coombs’
positive and Coombs’ negative dogs and between the in-
saline auto-agglutination positive and negative dogs.
The correlation between the number of spherocytes and
the OF50 was determined by calculating the Pearson’s
correlation coefficient with a global significance level
at 0.001.
For group 1, the number of reticulocytes (log trans-
formed) was compared between ROFT positive and
ROFT negative dogs by a t-test with a global significance
level at 0.05 and, by using the same test, OF5, OF50 and
OF90 were compared between dogs with regenerative
and dogs with non regenerative anaemia.
The sensitivity and specificity of the ROFT for diag-
nosing IMHA in anaemic dogs were determined based
upon the results from the dogs from group 1a and group
1b with a 95% confidence interval. All statistical tests
were performed by using SAS version 9.2.
Results
Animals
In total, 92 dogs were included and divided among 6
groups. Signalment data of all dogs are presented in
Table 1. Table 2 presents the clinical diagnosis for all
dogs.
Laboratory tests
For all groups, the results of the PCV, MCV, Chol, TG
and number of spherocytes on the blood smear are sum-
marized in Table 3. For group 1a the anaemia was regen-
erative in 14/19 (74%) of the dogs, while it wasregenerative in 11/21 (53%) of group 1b dogs. The mini-
mum, maximum and median absolute reticulocyte count
were respectively 3000/μl, 249000/μl and 81000/μl for
group 1a and 7340/μl, 329260/μl and 100000/μl for
group 1b. The dogs from group 1a with ‘no spherocyto-
sis’ were diagnosed with primary IMHA, based on a posi-
tive in-saline auto-agglutination (n = 3) and/or Coombs’
test (n = 2) and the absence of an underlying cause for the
anaemia. None of the dogs in group 1b, 2, 3 or 5 with
mild, moderate or marked spherocytosis, showed signs of
haemolysis, and they all had a negative Coombs’ and in-
saline auto-agglutination test.
The results of the in-saline auto-agglutination and
Coombs’ tests are summarized in Table 3. Three dogs with
IMHA had both a negative in-saline auto-agglutination as
well as Coombs’ test. IMHA was diagnosed in these dogs
based on the presence of hyperbilirubinaemia, bilirubi-
nuria, a moderate (n = 2) to marked (n = 1) spherocytosis
and the absence of another cause of anaemia. In group 1a,
the Coombs’ test was not performed in two dogs because
of unavailability of a sufficient volume of blood. These
dogs were diagnosed with IMHA based upon the presence
of haemolytic anaemia with a mild (n = 1) or marked
spherocytosis (n = 1) together with a positive in-saline
auto-agglutination test. The group 1b dog with a positive
Coombs’ test showed Heinz bodies without spherocytes
on the blood smear and was diagnosed with methemoglo-
binaemia due to an onion intoxication. Two dogs from
group 5 had a positive Coombs’ test, due to Ehrlichiosis
and Leishmaniosis. IMHA was excluded because no signs
of haemolytic anaemia were present and all other tests for
IMHA were negative.
Table 4 presents the ROFT and COFT results.
Overall, the ROFT was positive in 17/19 (89.4%) of
dogs with IMHA and in 12/73 (16.4%) of dogs without
IMHA. The two dogs of group 1a with a negative ROFT
had primary IMHA and the lowest OF5 and OF50 values
of their group. In both dogs, no spherocytes were seen
on the blood smear. From the dogs with IMHA with a
positive ROFT only one dog had no spherocytosis, while
the other dogs had mild (n = 2), moderate (n = 2) or
marked (n = 12) spherocytosis. The colour change was
very obvious in all 17 dogs from group 1a with a positive
ROFT, but was only mildly discernible in the one dog
from group 1b with a positive ROFT. This dog, which
had anaemia due to chronic kidney disease (Inter-
national Renal Interest Society stage III), had no sphero-
cytosis. The ROFT was positive in 10/13 (77%) dogs of
group 3, with an obvious colour change in seven dogs
and a mild colour change in 3 dogs. Two dogs had mild
spherocytosis and eight dogs had no spherocytosis. Two
of them had only hypercholesterolemia, three only
hypertriglyceridemia and five dogs had both hyperchol-
esterolemia and hypertriglyceridemia. In the majority of
Table 1 Signalment data for group 1a (IMHA), group 1b (anaemia, no IMHA), group 2 (microcytosis), group 3
(hyperlipidemia), group 4 (lymphoma), group 5 (infections) and group 6 (healthy)
Group Breeds Sex Age (years)
1a (n = 19) Shih Tzu (n = 3), Belgian Shepherd (n = 3), Kuvasz (n = 1), Maltese Dog (n = 1),
Great Dane (n = 1), American Cocker Spaniel (n = 1), Miniature Pincher (n = 1),
Rottweiler (n = 1), Border Collie (n = 1), American Staffordshire Terrier (n = 1),
Fox Terrier (n = 1), Labrador Retriever (n = 1), Jack Russell Terrier (n = 1),
Dutch Partridge Dog (n = 1), mixed breed (n = 1)
F (n = 6) 4.9 ± 2.7 (0.5-10)
FN (n = 5)
M (n = 6)
MN (n = 2)
1b (n = 21) Bernese Mountain Dog (n = 4), Jack Russell Terrier (n = 4), Belgian Shepherd
(n = 2), mixed breed (n = 2), Maltese Dog (n = 2), Miniature Schnauzer (n = 2),
Beagle (n = 1), Labrador Retriever (n = 1), Miniature Pincher (n = 1), Cavalier King
Charles Spaniel (n = 1), Big Münsterländer (n = 1)
F (n = 6) 7.2 ± 4.3 (0.5-14)
FN (n = 5)
M (n = 8)
MN (n = 2)
2 (n = 8) Labrador Retriever (n = 2), Doberman Pincher (n = 1), Jack Russell Terrier (n = 1),
Maltese Dog (n = 1), Yorkshire Terrier (n = 1), mixed breed (n = 1),
American Staffordshire Terrier (n = 1)
F (n = 2) 8.6 ± 3.5 (1–12)
FN (n = 2)
M (n = 3)
MN (n = 1)
3 (n = 13) Mixed breed (n = 2), Yorkshire Terrier (n = 2), Jack Russell Terrier (n = 1),
Boxer (n = 1), Fox Terrier (n = 1), Cavalier King Charles Spaniel (n = 1),
Weimaraner (n = 1), English Cocker Spaniel (n = 1), Golden Retriever (n = 1),
Newfoundlander (n = 1), Wolfspitz (n = 1)
F (n = 2) 9.3 ± 2.9 (3–13)
FN (n = 2)
M (n = 7)
MN (n = 2)
4 (n = 10) Vizla (n = 1), Bernese Mountain Dog (n = 1), American Cocker Spaniel (n = 1),
Fox Hound (n = 1), Dogo Argentino (n = 1), Golden Retriever (n = 1),
Border Collie (n = 1), American Staffordshire Terrier (n = 1), Daschound (n = 1),
Bouvier des Flandres (n = 1)
F (n = 2) 7.9 ± 2.4 (4–12)
FN (n = 2)
M (n = 4)
MN (n = 2)
5 (n = 8) German Pointer (n = 1), Fila Brasileiro (n = 1), American Staffordshire
Terrier (n = 1), Cavalier King Charles Spaniel (n = 1), Chow Chow (n = 1),
Labrador Retriever (n = 1), Beauceron (n = 1), mixed breed (n = 1)
F (n = 4) 6.7 ± 3.8 (2–13)
M (n = 4)
6 (n = 13) Mixed breed (n = 3), Nova Scotia Duck Tolling Retriever (n = 2),
Maltese Dog (n = 2), Labrador Retriever (n = 2), Jack Russell Terrier (n = 1),
Boxer (n = 1), Border Collie (n = 1), English Staffordshire Terrier (n = 1)
F (n = 5) 6.1 ± 3.5 (1–11)
FN (n = 1)
M (n = 4)
MN (n = 3)
The data for age are expressed as mean ± standard deviation (range).
F: female; FN: female neutered; M: male; MN: male neutered.
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supernatant was detected in both ROFT tubes after cen-
trifugation. Finally, although the colour change was very
mild, the ROFT was considered positive in one healthy
dog (group 6), with a serum TG concentration that
approached the upper reference limit. This dog did not
have spherocytosis and did not have higher values for
OF5, OF50 and OF90 compared to the rest of his group.
After centrifugation, the supernatant was cloudy in both
ROFT tubes.
Statistical analysis
Compared to the healthy dogs of group 6, OF5 and
OF50 of group 1a (P < 0.001) and OF5 of group 3 dogs
(P = 0.0266) were significantly higher. The other compar-
isons of OF5, OF50 and OF90 among groups did not re-
veal statistically significant differences. The higher values
for OF5 and OF50 in group 1a dogs resulted in amarked left shift of the cumulative and derivative fragili-
gram. Only two dogs of group 3, those with the highest
values of OF5 and OF50 within their group, and none of
the others had a left shift of their fragiligrams. Figure 1
depicts the fragiligrams obtained based on the mean
values for OF5, OF50 and OF90 of group 1a (IMHA),
group 3 (hyperlipidemia) and group 6 (healthy dogs).
Furthermore, it was found that dogs with a positive
ROFT had a significant lower PCV (P = 0.041), higher
MCV (P = 0.005), higher number of spherocytes (P <
0.001), higher Chol (P < 0.001) and higher TG concentra-
tions (P < 0.001). Also, a significant positive correlation
was found between the number of spherocytes and the
OF50 (r: 63%; P < 0.001).
In comparison, dogs with a positive Coombs’ test had
a significantly lower PCV (P < 0.001) and a higher num-
ber of spherocytes (P < 0.001), while MCV (P = 0.100),
Chol (P = 0.831) and TG concentrations (P = 0.452) were
Table 2 The clinical diagnosis for group 1a (IMHA), group 1b (anaemia, no IMHA), group 2 (microcytosis), group 3
(hyperlipidemia), group 4 (lymphoma), and group 5 (infections)
Group Disease category Diseases
1a (n = 19) Immune-mediated haemolytic anaemia Primary immune-mediated haemolytic anaemia (n = 17), secondary
immune-mediated haemolytic anaemia (n = 2): right hind limb abscess,
after Permethrin and Imidacloprida treatment
1b (n = 21) Anaemia, no immune-mediated
haemolytic anaemia
Splenic hemangiosarcoma (n = 5), histiocytic sarcoma (n = 2), disseminated
mastocytoma (n = 1), gastro-intestinal bleeding due to long-term NSAID administration
(n = 2) and intestinal neoplasia (n = 2), coumarine intoxication (n = 2), methemoglobinemia
due to onion intoxication (n = 1), blood loss due to immune-mediated thrombocytopenia
(n = 2), chronic kidney disease (n = 1), hypoadrenocorticism (n = 1), factor X deficiency
(n = 1), anaemia of inflammatory disease (n = 1)
2 (n = 8) Microcytosis Iron deficiency due to chronic gastro-intestinal blood loss (n = 6), hypoadrenocorticism
(n = 1), portosystemic shunt (n = 1)
3 (n = 13) Hyperlipidemia Hyperadrenocorticism (n = 7), diabetic ketoacidosis with pancreatitis (n = 1), pancreatitis
(n = 1), cholestatic liver disease (n = 1), hypothyroidism (n = 1), nephrotic syndrome (n = 1),
primary hyperlipidemia (n = 1)
4 (n = 10) Multicentric Lymphoma B-cell lymphoma (n = 5), T-cell lymphoma (n = 2), lymphoma with unknown
immunophenotype (n = 3)
5 (n = 8) Infectious disease Pyometra (n = 2), septic peritonitis (n = 2), prostatitis (n = 1), chronic Erlichiosis (n = 1),
Leishmaniasis (n = 1), septic pericarditis (n = 1)
aAdvantix®, Bayer Health Care, Brussels, Belgium.
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Coombs and a negative Coombs’ test. Dogs with a posi-
tive Coombs’ test and dogs with a positive in-saline
auto-agglutination test also had a significantly higher
OF50 (P < 0.001).
For group 1, there was no significant difference in the
number of reticulocytes between dogs with a positive
ROFT and dogs with a negative ROFT (P = 0.874). Fur-
thermore, there was no significant difference for OF5
(P = 0.228), OF50 (P = 0.234) or OF90 (P = 0.360) be-
tween dogs with regenerative anaemia and dogs with
non regenerative anaemia.
The sensitivity and specificity for the ROFT for diag-
nosing IMHA in dogs with anaemia were respectively
89% and 95%.
Discussion
Diagnosing canine IMHA is often challenging because
all currently available tests have their limitations [1,2]. In
human medicine two criteria must be met to diagnose
immune-mediated haemolytic anaemia: serological evi-
dence of an autoantibody by positive Coombs’ test and
clinical and/or laboratory evidence of haemolysis [29]. In
veterinary medicine, diagnosis is similar, but as there is
no accepted ‘gold standard’, diagnosis is based upon the
presence of haemolytic anaemia in combination with the
demonstration of spherocytosis, positive in-saline auto-
agglutination and/or Coombs’ test [2].
This study evaluated the OF in dogs with and without
IMHA, mainly to assess the diagnostic value of the
ROFT as additional test to detect canine IMHA.
A significant increase in OF5 and OF50 and a left shift
of the fragiligrams were observed in dogs with IMHA.More importantly, the ROFT was positive in 89% of
dogs with IMHA. Few studies evaluated OF in anaemic
dogs. Paltrinieri et al. [30] used the COFT in 25 healthy
and 40 anaemic dogs and found a significant increase in
OF5 in dogs with regenerative anaemia (9/15 with
haemolytic anaemia) compared to healthy dogs and dogs
with non regenerative anaemia. However, they did not
specify how many dogs with haemolytic anaemia had
immune-mediated disease. In this study, we did not find
a significant difference in OF5, OF50 and OF90 between
dogs with regenerative and dogs with non regenerative
anaemia. Furthermore, the number of reticulocytes was
not significantly different between anaemic dogs with a
positive ROFT and anaemic dogs with a negative ROFT.
To the authors’ knowledge, this study is the first to re-
port the results of COFT and ROFT in a group of dogs
with IMHA.
A significant increase in OF5 was also found in dogs
with natural occurring hyperlipidemia and 77% of them
had a positive ROFT. Furthermore, dogs with a positive
ROFT had a significantly higher serum cholesterol and
triglyceride concentration. However, in contrast with the
IMHA dogs, OF50 was not significantly higher in hyper-
lipidemic dogs compared with healthy dogs and only 2/
13 hyperlipidemic dogs had a left shift of their fragili-
grams. This indicates that only a minor subpopulation of
RBCs is responsible for the increased OF in the dogs
with hyperlipidemia. Previously, hypercholesterolemia,
experimentally induced by feeding healthy dogs a
cholesterol-enriched atherogenic diet resulted in an in-
creased OF, a decreased PCV and altered RBC morph-
ology after 6 weeks [19]. Although not yet reported in
dogs, hypertriglyceridemia can have similar effects and
Table 3 Results of the packed cell volume, mean corpuscular volume, cholesterol and triglyceride concentration, number
of spherocytes, in-saline auto-agglutination and Coombs’ test for group 1a (IMHA), group 1b (anaemia, no IMHA), group 2
(microcytosis), group 3 (hyperlipidemia), group 4 (lymphoma), group 5 (infections) and group 6 (healthy)
Group 1a
(n = 19)
Group 1b
(n = 21)
Group 2
(n = 8)
Group 3
(n = 13)
Group 4
(n = 10)
Group 5
(n = 8)
Group 6
(n = 13)
Packed Cell Volume (%) 13.6 ± 4.8 17.9 ± 4.3 25.0 ± 14.7 46.8 ± 9.9 44.1 ± 11.8 30.3 ± 15.1 46.9 ± 3.6
(7.6-23) (7.0-25.5) (11.0-55.2) (18.2-57.7) (20.5-59.4) (14.9-61.4) (41.7-53.2)
Mean Corpuscular Volume (fl) 76.7 ± 5.1 77.7 ± 9.3 57.1 ± 3.3 68.9 ± 8.1 70.4 ± 4.5 66.5 ± 5.4 68.7 ± 2.4
(70.7-88.4) (67.1-96.3) (50.4-60.0) (62.7-77.2) (62.9-77.3) (60.0-76.7) (63.0-71.2)
Cholesterol concentration (mmol/l) 6.73 ± 1.37 4.68 ± 3.18 3.58 ± 1.83 16.6 ± 11.0 4.95 ± 1.44 6.33 ± 1.48 6.81 ± 1.45
(5.3-8.53)* (0.83-12.7)** (2.48-8.35) (6.26-48.38) (2.77-7.11) (4.0-9.0) (4.42-9.15)
Triglyceride Concentration (mmol/l) 0.87 ± 0.30 0.76 ± 0.28 0.71 ± 0.44 11.73 ± 9.36 0.75 ± 0.31 0.90 ± 0.34 0.89 ± 0.56
(0.57-1.25)* (0.41-1.19)** (0.24-1.72) (0.86-29.26) (0.44-1.34) (0.52-1.56) (0.31-1.99)
Number of spherocytes per high
power field
<1 3 13 7 11 10 7 13
1-3 2 4 1 2 0 0 0
3-5 2 3 0 0 0 0 0
≥5 12 1 0 0 0 1 0
In-saline auto-agglutination Positive 16 0 0 0 0 0 0
Negative 3 21 8 13 10 8 13
Coombs’ test Positive 13 1 0 0 0 2 0
Negative 4*** 20 8 13 10 6 13
The data of the packed cell volume, the mean corpuscular volume, the cholesterol and triglyceride concentration are expressed as mean ± standard deviation (range).
*Total serum cholesterol and triglyceride concentrations were measured in 4/19 group 1a dogs.
**Total serum cholesterol and triglyceride concentrations were measured in 13/21 group 1b dogs.
***Coombs’ test was performed in 17/19 group 1a dogs.
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in mice and humans [21,22]. Our study is the first
reporting an increased OF in dogs with natural occur-
ring hyperlipidemia. In contrast to the dogs with experi-
mentally induced hypercholesterolemia, none of the
dogs of our study with hyperlipidemia developed an-
aemia, nor showed changes in RBC morphology. Further
research is needed to elucidate why not all dogs withTable 4 Results of the rapid osmotic fragility test (ROFT) and c
group 1b (anaemia, no IMHA), group 2 (microcytosis), group 3
and group 6 (healthy)
. Group 1a
(n = 19)
Group 1b
(n = 21)
Group 2
(n = 8)
ROFT Positive 17 1 0
Negative 2 20 8
COFT OF5 0.75 ± 0.11* 0.51 ± 0.11 0.53 ± 0.13
(%) (0.51-0.85) (0.37-0.83) (0.43-0.81
OF50 0.64 ± 0.12* 0.39 ± 0.06 0.39 ± 0.05
(%) (0.44-0.83) (0.28-0.52) (0.35-0.49
OF90 0.38 ± 0.17 0.27 ± 0.10 0.26 ± 0.09
(%) (0.28-0.64) (0.06-0.43) (0.10-0.36
Data of the COFT are expressed as mean ± standard deviation (range).
OF5, OF50, OF90 are the NaCl concentration at which respectively 5, 50 and 90% o
OF5, OF50 or OF90 from all clinical groups (group 1–5) were compared with the co
*Denotes a statistically significant difference from the control group for the respecthypercholesterolemia and/or hypertriglyceridemia have an
increased OF, what the role of the underlying disease
process is and what the exact mechanisms are for the in-
creased OF in dogs with natural occurring hyperlipidemia.
Changes in OF were not detected in dogs with micro-
cytosis, lymphoma or infections, in contrast to previous
studies for dogs with microcytosis [16,17]. The latter re-
ported an increased OF, with a mild left shift of theirlassic osmotic fragility test (COFT) for group 1a (IMHA),
(hyperlipidemia), group 4 (lymphoma), group 5 (infections)
Group 3
(n = 13)
Group 4
(n = 10)
Group 5
(n = 8)
Group 6
(n = 13)
10 0 0 1
3 10 8 12
0.64 ± 0.14* 0.52 ± 0.06 0.49 ± 0.04 0.51 ± 0.04
) (0.43-0.84) (0.44-0.66) (0.44-0.52) (0.46-0.54)
0.45 ± 0.05 0.42 ± 0.04 0.39 ± 0.04 0.44 ± 0.03
) (0.33-0.53) (0.36-0.47) (0.34-0.42) (0.40-0.49)
0.34 ± 0.07 0.36 ± 0.04 0.27 ± 0.10 0.34 ± 0.09
) (0.18-0.40) (0.31-0.45) (0.07-0.35) (0.06-0.40)
f RBCs are hemolysed.
ntrol group (group 6). The global significance level was set at 0.05.
ive response variable.
Figure 1 Cumulative and derivative fragiligram for group 1a (IMHA), group 3 (hyperlipidemia) and group 6 (healthy dogs). The
cumulative (dark line) and derivative (light line) fragiligrams are based on the mean values for OF5, OF50 and OF90 of group 1a (dogs with
IMHA), group 3 (dogs with hyperlipidemia) and group 6 (healthy dogs) in the COFT. The figure shows a marked left shift of the cumulative and
derivative fragiligram in dogs from group 1a, while no obvious left shift of the fragiligrams is present in dogs from group 3 or group 6. Furthermore, it
can be noticed that the NaCl concentration at which 5% of the erythrocytes are haemolysed is higher for group 3 than for group 6, which indicates
that in group 3 a small subpopulation of erythrocytes has an increased osmotic fragility.
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ternal parasitism. Remarkably, we found that dogs with a
positive ROFT had a significant higher MCV (P = 0.005)
than dogs with a negative ROFT. However, in our study,
no dogs had internal parasitism and only a limited num-
ber with microcytosis was included, which limits our
conclusions about OF and microcytosis in dogs. The in-
fluence of neoplasia and infections has yet to be re-
ported. These disease groups were included because
previous studies have detected RBC bound antibodies in
dogs with neoplasia and dogs that were diagnosed with
various infectious diseases without any other additional
criteria for the diagnosis of IMHA [1,31]. The clinical
relevance of detecting RBC antibodies in non-anaemic
dogs is unclear at presence [1]. In our study, the
Coombs’ test was positive in two dogs with an infection
without signs of haemolytic anaemia. Both dogs had a
normal COFT and a negative ROFT. However, because
the group of dogs with infections was very heteroge-
neous and only a small number of dogs with infections
was included it is difficult to draw conclusions about OF
in dogs with infections based on this study. Further re-
search evaluating OF in dogs with specific infectious
conditions is warranted.
The dogs with an increased OF did not belong to one
of the breeds in which hereditary erythrocyte membrane
defects that can cause an increased OF have been de-
scribed [7-15]. However, we cannot completely rule out
an erythrocyte membrane defect as the cause for the in-
creased OF in these dogs, as, although not yet reported,
erythrocyte membrane defects may probably also occur
in other breeds. However, in our opinion, it is very un-
likely that an erythrocyte membrane defect was the sole
cause of the increased OF in the dogs of our study, be-
cause all dogs with an increased OF had additional cri-
teria for immune-mediated red cell destruction or had
pronounced hyperlipidemia.
Overall, the COFT and ROFT showed similar results
in our study population. The ROFT was only positive in
dogs with increased OF5 and/or OF50. While the COFT
is labour-intensive, the ROFT is a rapid test that can be
performed easily in daily practice. However, the COFT
provides more detailed information about the OF. For
example, the majority of dogs with hyperlipidemia had a
positive ROFT, indicating that OF was increased, while
the COFT revealed that only OF5 was significantly in-
creased and that, with the exception of two dogs, no left
shift of the fragiligrams was present in hyperlipidemic
dogs. This was in contrast with what was found for dogs
with IMHA, that showed an increase in OF5 and OF50
together with an obvious left shift of their fragiligrams.
A remarkable finding of this study was that the ROFT
had a high sensitivity (89%) to diagnose IMHA in dogs
in this study. This is an important finding, because a lowsensitivity has been reported for some of the other diag-
nostic tests that are used to diagnose IMHA in dogs,
such as the Coombs’ test. The sensitivity of the Coombs’
test has been reported to range between 37 and 89 per
cent, but is generally considered to be in the region of
60 per cent [1,32-35]. Also in human medicine ‘Coombs
negative auto-immune haemolytic anaemia’ is reported
in 1-10% of patients [36]. The large range in sensitivity
of the Coombs’ test can be explained because there is no
standardized set up of the Coombs’ test in different
laboratories [2]. In this study, a commercial available
gel-based direct Coombs’ test was used, that has good
agreement with the traditional direct Coombs’ test [28].
However, false negatives can occur with the gel-based
test. Furthermore, it is reported that the Coombs’ test
can quickly become negative after starting treatment
with immunosuppressive dosages of corticosteroids and
that this can already occur after one day of treatment
[28]. In this study, dogs were only excluded if they
received medication for longer than 3 days prior to ad-
mission. However, only four anaemic dogs received cor-
ticosteroids and they all had a positive Coombs’ test. As
the sensitivity of the ROFT in our study was only based
on a small number of dogs, the results need to be inter-
preted with caution.
Furthermore, the ROFT had a high specificity (95%)
for diagnosing IMHA in anaemic dogs. To accurately
determine the specificity of a test, the test should be
evaluated in a large population of randomly selected sick
and non-sick dogs. However, certain patient groups in
our study were included because previous studies docu-
mented abnormal OF test results in dogs with these dis-
eases, which resulted in a population of sick dogs that
was not randomly selected. Therefore, we could only
calculate the specificity of the ROFT for diagnosing
IMHA in the anaemic dogs (group 1a and 1b). Further
studies are needed to determine the overall specificity of
the ROFT and the positive and negative predictive value
of this test.
Although, based on the results of this study, the ROFT
appeared to be a valuable and practical additional test
for diagnosing IMHA in dogs with anaemia, the test has
some disadvantages. As it has been assumed that the
ROFT is based on the presence of spherocytes and be-
cause a moderate to marked spherocytosis is only
present in 75 to 94% of dogs with IMHA, false negative
results may be expected [35,37,38]. However, although
we found that dogs with a positive ROFT had a higher
number of spherocytes on their blood smear than dogs
with a negative ROFT and that a positive correlation was
present between the number of spherocytes and the
OF50, it was seen that from the 17 dogs with IMHA and
a positive ROFT, one dog had no spherocytosis and two
dogs had only mild spherocytosis. In accordance with
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dogs with IMHA, while the OF test, that was performed
in 142 of these dogs, was positive in 117 dogs [4]. It is
possible that the ROFT has a higher sensitivity for
IMHA because low to moderate numbers of spherocytes
may not be detected on the blood smear. However, it is
more likely that factors other than the presence of
spherocytes play a role in the development of the in-
creased OF in dogs with IMHA. It has been reported
that in dogs with IMHA a state of oxidative stress and a
reduced antioxidant reserve is present [39]. Oxidative
stress is thought to aggravate the symptoms of many dis-
eases, including haemolytic anaemias, because erythro-
cytes are highly susceptible to oxidative damage induced
by free radicals or reactive oxygen species [40,41]. Stud-
ies in goats, pigs and donkeys showed that stressful con-
ditions such as transportation and packing induced a
significant increase in the erythrocyte OF that was not
present when the animals were treated with an anti-
oxidant (ascorbic acid) before undergoing the stressful
event, suggesting that the increased OF was a conse-
quence of oxidative stress [41-43]. Although, not yet
studied, oxidative stress may have similar effects on ca-
nine erythrocytes and may contribute to the increased
OF that is seen in dogs with IMHA. Furthermore, dogs
with IMHA are reported to have activated platelets that
produce prostaglandin E2 (PGE2) [38]. In humans, it has
been reported that PGE2 reduces erythrocyte filterability
by stimulating potassium efflux leading to a loss of os-
motic water and cell shrinkage [44]. Although, it might
be expected that these erythrocytes with a lower volume
to surface ratio have an increased OF, it was found that
the erythrocyte OF was decreased. Further studies are
necessary to evaluate if the effect of PGE2 on canine
erythrocyte OF is similar.
A second disadvantage of the ROFT is that a dog can
be diagnosed incorrectly with IMHA based on a positive
result of the ROFT. In this study, 12 dogs that did not
have IMHA, had a positive ROFT. However, some differ-
ences were present between the dogs with IMHA and
the dogs without IMHA that had a positive ROFT. First,
the colour change was very mild in one anaemic dog,
one control dog and three dogs with hyperlipidemia with
a positive ROFT, while in all dogs with IMHA the
change was very obvious. Moreover, in the majority of
dogs that did not have IMHA, the supernatant in both
ROFT tubes was cloudy, due to hyperlipidemia, while it
was clear in all dogs with IMHA.
Unfortunately, as with other diagnostic tests for
IMHA, such as the Coombs’ test, in-saline auto-
agglutination test and presence of spherocytosis, the
ROFT cannot distinguish between primary and second-
ary IMHA. Finally, the quality of the osmotic fragility
test may be influenced by environmental and technicalfactors. Therefore, it is important that the technical con-
ditions of the assay are strictly standardized [45]. Also,
the choice of the anticoagulant can affect the results. For
this study, we chose heparinised blood, mainly because,
in humans, use of EDTA as an anticoagulant has been
described to increase the RBC OF [45]. Using hepari-
nised instead of EDTA blood has as disadvantage that a
larger amount of blood needs to be taken in patients
that may have a life threatening anaemia. Although only
10 drops of blood are needed to perform the ROFT, it
might be more interesting to perform the test on EDTA
blood. Further research evaluating the ideal anticoagu-
lant in dogs is warranted. Furthermore, although not
seen in the dogs in this study, in dogs with severe hae-
moglobinaemia due to intravascular haemolysis, the
supernatant can be red in both ROFT tubes. In these
cases the difference in colour between both ROFT tubes
might be only mild. Therefore, it can be more difficult
to interpret test results in case of severe haemoglobinae-
mia. Haemoglobinaemia is present in the minority of
dogs with IMHA and is caused by immunoglobulin M
(IgM)-mediated haemolysis and subsequent intravascular
complement activation with intravascular haemolysis
[4,29,46]. However, overwhelming complement activa-
tion usually is required to produce clinically evident
intravascular haemolysis [29]. In contrast with IgM, im-
munoglobulin G (IgG), which is the most common Ig
isotype associated with IMHA in dogs, is a poor activa-
tor of the complement system and therefore causes
mainly extravascular haemolysis by macrophages in the
liver and/or spleen [29]. In this study, the influence of
intravascular versus extravascular haemolysis on OF was
not studied, because only few dogs showed signs of
intravascular haemolysis (haemoglobinaemia and/or
haemoglobinuria) and because some dogs with IMHA
have both IgG and IgM antibodies which can result in
the combination of intravascular and extravascular
haemolysis [4,47]. Finally, as it is unclear if in vitro
haemolysis has an influence on COFT and ROFT results,
the authors advise to perform analysis, when possible,
on blood samples that are not haemolytic. Also, at the
moment it is not known if the degree of anaemia might
influence the results of the OF tests. Further studies
evaluating this are necessary.
Although our results are promising, this study has
some limitations. Only a limited number of dogs were
included. Furthermore, serum cholesterol and TG con-
centrations were not measured in every anaemic dog be-
cause some of these dogs were not fasted and/or not
enough blood could be taken from very anaemic dogs.
Nevertheless, it seems highly unlikely that dogs with
IMHA had a positive ROFT due to hyperlipidemia as
their serum was clear, while it was lipemic in the major-
ity of dogs with hyperlipidemia. Also, none of the dogs
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ary hyperlipidemia and none of the dogs with IMHA in
which the cholesterol and TG concentration was not
measured, belonged to a breed in which primary hyper-
lipidemia has been reported [48]. Finally, in this study
spherocytosis was quantified microscopically as counts
per oil immersion fields. A disadvantage of our grading
system is that the number of spherocytes per high power
field depends on the haematocrit [2]. Therefore, calculat-
ing the percentage of spherocytes might be more reli-
able. A grading system in which the number of
spherocytes as well as the percentage of spherocytes is
included has recently been described [49]. In this system
spherocytosis is scored from 1+ to 4+. 1+ equals 5–10
spherocytes per oil immersion field (2-4%), 2+ equals
11–50 per oil immersion field (4-20%), 3+ equals 51–
150 per oil immersion field (20-60%), and 4+ equals >150
per oil immersion field (>60%). Because no percentages of
spherocytes were calculated in our study, it is impossible
to compare the results for spherocytosis from our study
with the recently described scoring system. In most previ-
ous studies only the presence of spherocytes, without grad-
ing spherocytosis, was taken into account [4,28,34,46,50].
In one recent study, a grading system for spherocytosis
was used, but it was unclear from the report if this was
based on counts per high power field or on percentages of
spherocytes [51]. To facilitate the comparison of future
studies, standardization of grading of spherocytosis is
needed in veterinary medicine. In this study, three dogs
were included in group 1a, based on the presence of
haemolytic anaemia and the presence of a moderate
(n = 2) or marked (n = 1) spherocytosis, while the
Coombs’ test and in-saline auto-agglutination test were
negative. Although Coombs’ negative IMHA is a well-
known phenomenon in dogs [1,32-35], we cannot rule out
that these dogs, especially the dogs with only a moderate
spherocytosis had haemolytic anaemia due to a non-
immune-mediated cause. These dogs were not tested for
hereditary erythrocyte membrane defects. However, this
seems less likely as one of these dogs was 6 years of age at
diagnosis and the other dog, which was younger than a
year, had a right hind limb abscess with a suspected sec-
ondary IMHA. The haemolytic anaemia in the latter dog
resolved with appropriate antibiotic therapy.
Conclusions
In conclusion, OF was increased in the majority of dogs
with IMHA and in dogs with hyperlipidemia, but not in
dogs with microcytosis, lymphoma or an infection. Al-
though more detailed information was obtained about
the OF by using the COFT, the COFT and ROFT gave
similar results. The ROFT does not require specialized
equipment, is rapid and easy to perform and can be used
easily in daily practice. Although, the ROFT cannotreplace other diagnostic tests, it may be a valuable add-
itional tool to diagnose IMHA. Further studies are
needed to explain the reason for an increased OF in
dogs with IMHA. The degree of spherocytosis likely
contributes, but other factors may be involved. Finally,
studies with larger number of dogs need to reveal the
ideal test conditions and test performances. Because of
this, the authors conclude that only anaemic dogs with a
positive ROFT, characterized by a clear supernatant that
is colourless in the first tube and red in the second tube,
are highly likely to have IMHA.
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